Agricultural Research Service scientists and colleagues are looking inside the cow in order to spot -- and to stop -- bacteria that cause a particularly nasty E. coli-related disease.
Microbiologist Evelyn Dean-Nystrom and veterinary medical officer William Stoffregen of the ARS National Animal Disease Center (NADC) in Ames, Iowa, are pinpointing where microbes called enterohemorrhagic Escherichia coli O157:H7 lurk in calves.
Also, Nystrom is helping researchers at the Uniformed Services University of the Health Sciences in Bethesda, Md., develop and test an oral vaccine that eliminates these bacteria from cattle.
E. coli O157:H7 is the most common infectious cause of bloody diarrhea in people in the United States. Hemolytic uremic syndrome, a potential consequence of its infection, is the primary cause of acute kidney failure in U.S. children.
Undercooked or raw ground beef has been implicated in many E. coli O157:H7 outbreaks in humans. However, the causative bacteria have almost no discernable effect in cattle, making them hard to detect there.
Nystrom and Stoffregen found that, in addition to intestines, calves' gall bladders may be a good place to check whether an E. coli O157:H7 infection has taken place. This finding indicates that including gall bladders in samples cultured for E. coli O157:H7 may help identify infected cattle at slaughter.
The oral vaccine, developed at the Bethesda university by graduate student Nicole A. Judge, uses intimin, a protein on the outer membrane of the O157:H7 strain that the E. coli bacteria need for attaching themselves to intestinal tissue. Nystrom assisted with development of the vaccine -- supervised by microbiologist and department chair Alison O'Brien -- early on, by showing that calves injected with purified bacterial intimin would develop antibodies against it.
Nystrom works in NADC's Preharvest Food Safety and Enteric Diseases Research Unit, while Stoffregen works in the center's Bacterial Diseases of Livestock Research Unit.
Source: Agricultural Research magazine and ARS/U.S. Department of Agriculture
Pioneering Advances in Sterilization: The Future of Infection Control
November 28th 2024Germitec, STERIS, ASP, and Zuno Medical are pioneering sterilization advancements with groundbreaking technologies that enhance SPD workflows, improve patient safety, and redefine infection control standards.
Genomic Surveillance A New Frontier in Health Care Outbreak Detection
November 27th 2024According to new research, genomic surveillance is transforming health care-associated infection detection by identifying outbreaks earlier, enabling faster interventions, improving patient outcomes, and reducing costs.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.